Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of California, Davis
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Vanderbilt-Ingram Cancer Center
Sichuan University
Sichuan University
Humanetics Corporation
Weill Medical College of Cornell University
Clinica Universidad de Navarra, Universidad de Navarra
University of Pittsburgh
Case Comprehensive Cancer Center
NYU Langone Health
Abramson Cancer Center at Penn Medicine
University of Texas Southwestern Medical Center
Wake Forest University Health Sciences
Masonic Cancer Center, University of Minnesota
University of Washington
Hoosier Cancer Research Network
Alliance for Clinical Trials in Oncology
University of Alabama at Birmingham
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center
Betta Pharmaceuticals Co., Ltd.
Indiana University
University of Alabama at Birmingham
Radiation Therapy Oncology Group
Eli Lilly and Company
Barbara Ann Karmanos Cancer Institute
University of Alabama at Birmingham
Eli Lilly and Company
Northwestern University